August 29, 2017 - By Vivian Park

Shares of Beijing Leadman Biochemistry Co Ltd (SHE:300289) last traded at 12.1, representing a move of -5.1%, or -0.65 per share, on volume of 24.10 million shares. After opening the trading day at 12, shares of Beijing Leadman Biochemistry Co Ltd traded in a close range. Beijing Leadman Biochemistry Co Ltd currently has a total float of shares and on average sees shares exchange hands each day. The stock now has a 52-week low of 10.31 and high of 17.53.

Amid numerous setbacks in the past, China has still proven itself to have one of the most important economies not just in Asia but in the whole world. Trade and commerce is richly flourishing in the nation and the Shanghai Stock Exchange (SSE) is one of the reasons it does. It is also the best place to show full potential for Beijing Leadman Biochemistry Co Ltd and its colleagues.

The SSE, one of Chinas primary stock exchanges aside from the Shenzhen Stock Exchange, is a non-profit organization that is administered by the China Securities Regulatory Commission (CSRC). As of February, the SSE boasts with a market capitalization of $3.50 trillion, making it the fifth largest stock exchange in the world. In Asia, it is the second biggest stock exchange. The second biggest market in the world increased the chances of Beijing Leadman Biochemistry Co Ltd to catch attention of investors.

The SSE was established in 1866 but it had to close on December 5, 1941 when Japan invaded Shanghai. Operations did not resume until December 19, 1990.

Shortly after the relaunch of the SSE, the SSE Composite Index began operating on July 15, 1991 as the primary index measuring all stocks on the SSE based on market capitalization. It tracks companies using the Paasche weighted composite price index formula. Measuring more than 1,000 companies listed on the SSE means that the SSE Composite Index is a broad indicator of the Chinese economy. As a result, it had to have three sub-indices: 1) the SSE 380, which monitors the 380 most active companies; 2) the SSE 180, which monitors the 180 most active companies; and 3) the SSE 50, which monitors the 50 most active companies. Of course, in order to be included in the SSE 50, a company needs to first be included in the SSE 180 and the SSE 380. Similarly, in order for it to be included in the SSE 180, it first needs to be included in the SSE 380. The smaller the index, the clearer of a representation it is of the Chinese economy.

The SSE Composite Index has last seen its all-time high of 6,092.06 in October 2007, shortly before the 2008 Global Financial Crisis broke out; and its all-time low of 99.98 in December 1990 during the relaunch period of the SSE.

Companies listed on the SSE are classified into two types: 1) A shares, which are traded in yuan; and 2) B shares, which are traded in US dollar (USD). In the past, only domestic traders had been allowed to trade A shares. Foreign investors had been limited to B shares. However, the restriction was lifted in 2002, giving the Chinese economy more opportunities to grow immensely with greater foreign investments. It means more possibilities for Beijing Leadman Biochemistry Co Ltd.

The regular trading session on the SSE starts at 9:30 and ends at 11:30 in the morning and starts at 1:30 and ends at 3:00 in the afternoon. There is also a pre-market trading session that starts at 9:15 a.m. and lasts for 10 minutes.

China is Asias largest economy, which is why there is no better way to bet on the Asian trade and commerce environment than to invest on SSE stocks. Traders look on the liquidity of Beijing Leadman Biochemistry Co Ltd.

More notable recent Beijing Leadman Biochemistry Co Ltd (SHE:300289) news were published by: Businesswire.com which released: Enigma Diagnostics Signs Joint Venture Agreement with Beijing Leadman on October 22, 2014, also Businesswire.com with their article: Research and Markets: Diagnostic Reagent Industry in China 2015 published on June 09, 2015, Prnewswire.com published: China In-vitro Diagnostic Reagent Industry Report 2017-2021 Research and Markets on April 21, 2017. More interesting news about Beijing Leadman Biochemistry Co Ltd (SHE:300289) were released by: Businesswire.com and their article: IVD Market in China 2015-2024 Research and Markets published on February 15, 2016 as well as Prweb.coms news article titled: China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic with publication date: July 30, 2014.

Beijing Leadman Biochemistry Co., Ltd is a China firm principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. The company has market cap of $. The Companys diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. It currently has negative earnings. The Firm also produces diagnostic instruments and biochemical raw materials.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Originally posted here:
Beijing Leadman Biochemistry Co Ltd (300289) Decline -5.1% on Aug 29 - NormanObserver.com